The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
HIV‐1 Viral Escape in Cerebrospinal Fluid of Subjects on Suppressive Antiretroviral Treatment
Open accessAbstract
BACKGROUND: Occasional cases of viral escape in cerebrospinal fluid (CSF) despite suppression of plasma human immunodeficiency virus type 1 (HIV-1) RNA have been reported. We investigated CSF viral escape in subjects treated with commonly used antiretroviral therapy regimens in relation to intrathecal immune activation and central nervous system penetration effectiveness (CPE) rank. METHODS: Sixty-nine neurologically asymptomatic subjects treated with antiretroviral therapy >6 months and plasma HIV-1 RNA <50 copies/mL were cross-sectionally included in the analysis. Antiretroviral therapy regimens included efavirenz, lopinavir/ritonavir or atazanavir/ritonavir combined with tenofovir, abacavir, or zidovudine and emtricitabine or lamivudine. HIV-1 RNA was analyzed with real-time polymerase chain reaction assays. Neopterin was analyzed by enzyme-linked immunosorbent assay. RESULTS: Seven (10%) of the 69 subjects had detectable CSF HIV-1 RNA, in median 121 copies/mL (interquartile range, 54-213 copies/mL). Subjects with detectable CSF virus had significantly higher CSF neopterin and longer duration of treatment. Previous treatment interruptions were more common in subjects with CSF escape. Central nervous system penetration effectiveness rank was not a significant predictor of detectable CSF virus or CSF neopterin levels. CONCLUSIONS: Viral escape in CSF is more common than previously reported, suggesting that low-grade central nervous system infection may continue in treated patients. Although these findings need extension in longitudinal studies, they suggest the utility of monitoring CSF responses, as new treatment combinations and strategies modify clinical practice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents
(1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-128-12_part_2-199806151-00003 · Cited by 5,209
Updated research nosology for HIV-associated neurocognitive disorders
Antinori, A., Arendt, G., Becker, J. T., Brew, B. J., Byrd, D. A., Cherner, M., Clifford, D. B., Cinque, P., Epstein, L. G., Goodkin, K., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000287431.88658.8b · Cited by 2,630
Self-citationCD4+ Count–Guided Interruption of Antiretroviral Treatment
(2006) · New England Journal of Medicine · doi:10.1056/nejmoa062360 · Cited by 2,231
Price, R. W., & Brew, B. J. (1988) · Journal of Infectious Diseases · doi:10.1093/infdis/158.5.1079 · Cited by 1,368
Self-citationLetendre, S. (2008) · Archives of Neurology · doi:10.1001/archneurol.2007.31 · Cited by 825
The prevalence and incidence of neurocognitive impairment in the HAART era
Robertson, K. R., Smurzynski, M., Parsons, T. D., Wu, K., Bosch, R. J., Wu, J., McArthur, J. C., Collier, A. C., Evans, S. R., & Ellis, R. J. (2007) · AIDS · doi:10.1097/qad.0b013e32828e4e27 · Cited by 619
Canestri, A., Lescure, F., Jaureguiberry, S., Moulignier, A., Amiel, C., Marcelin, A. G., Peytavin, G., Tubiana, R., Pialoux, G., & Katlama, C. (2010) · Clinical Infectious Diseases · doi:10.1086/650538 · Cited by 405
Ellis, R. J., Hsia, K., Spector, S. A., Nelson, J. A., Heaton, R. K., Wallace, M. R., Abramson, I., Atkinson, J. H., Grant, I., & McCutchan, J. A. (1997) · Annals of Neurology · doi:10.1002/ana.410420503 · Cited by 321
Edén, A., Price, R. W., Spudich, S., Fuchs, D., Hagberg, L., & Gisslén, M. (2007) · The Journal of Infectious Diseases · doi:10.1086/523648 · Cited by 174
Self-citationSpudich, S. S., Nilsson, A. C., Lollo, N. D., Liegler, T. J., Petropoulos, C. J., Deeks, S. G., Paxinos, E. E., & Price, R. W. (2005) · BMC Infectious Diseases · doi:10.1186/1471-2334-5-98 · Cited by 161
Self-citation
Cited by
Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function
Viale, A., Pettazzoni, P., Lyssiotis, C. A., Ying, H., Sánchez, N., Marchesini, M., Carugo, A., Green, T., Seth, S., Giuliani, V., et al. (2014) · Nature · doi:10.1038/nature13611 · Cited by 1,259
Clinical Metagenomic Sequencing for Diagnosis of Meningitis and Encephalitis
Wilson, M. R., Sample, H. A., Zorn, K. C., Arevalo, S., Yu, G., Neuhaus, J., Federman, S., Stryke, D., Briggs, B., Langelier, C., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1803396 · Cited by 1,067
HIV-associated neurocognitive disorder
Clifford, D. B., & Ances, B. M. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70269-x · Cited by 670
Microglial Cells: The Main HIV-1 Reservoir in the Brain
Wallet, C., De Rovere, M., Van Assche, J., Daouad, F., De Wit, S., Gautier, V., Mallon, P. W. G., Marcello, A., Van Lint, C., Rohr, O., et al. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00362 · Cited by 368
Controversies in HIV-associated neurocognitive disorders
Nightingale, S., Winston, A., Letendre, S., Michael, B. D., McArthur, J. C., Khoo, S., & Solomon, T. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70137-1 · Cited by 294
Metadata
- Authors
- Edén, A., Fuchs, D., Hagberg, L., Nilsson, S., Spudich, S., Svennerholm, B., Price, R. W., & Gisslén, M.
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-12-15
- Volume
- 202
- Issue
- 12
- Pages
- 1819-1825
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2120653113
- Cited by
- 286
- References
- 20
- FWCI
- 5.05
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: HIV‐1 Viral Escape in Cerebrospinal Fluid of Subjects on Suppressive Antiretroviral Treatment. https://app.cochat.ai/papers/10.1086/657342
- The paper
- Edén, A., Fuchs, D., Hagberg, L., Nilsson, S., Spudich, S., Svennerholm, B., Price, R. W., & Gisslén, M. (2010). HIV‐1 Viral Escape in Cerebrospinal Fluid of Subjects on Suppressive Antiretroviral Treatment. The Journal of Infectious Diseases. https://doi.org/10.1086/657342
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.